QQQ
-6.78
396.69
-1.74%
BTC/USD
-5995.65
47605.40
-11.19%
DIA
-0.37
346.98
-0.11%
SPY
-4.16
461.56
-0.91%
TLT
+ 1.82
150.71
+ 1.19%
GLD
+ 1.39
163.85
+ 0.84%

Orthogonal Thinker Files For Patent For Its Psilocybin Product, Psilly

April 14, 2020 2:04 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Orthogonal Thinker Files For Patent For Its Psilocybin Product, Psilly

Biotechnology company Orthogonal Thinker has filed an application for a proprietary psilocybin product with the United States Patent and Trademark Office (USPTO).

The Kihei, Hawaii-based company, which is focused on whole plant products as well as psychoactive compounds, has leveraged a proprietary formulation that uses natural alkaloids to produce its flagship product, Psilly.

Encuentra tus noticias sobre psicodélicos en Español en El Planteo.

Management said it utilized a portion of the more than $5 million it raised in seed capital to pursue development of the product. 

“Our proprietary psilocybin patent application is a crucial step in advancing our efforts to ensure the viability of our cutting edge medicines," Jason Hobson, CEO of Orthogonal Thinker, told Benzinga. "We couldn’t be more excited or grateful.”

Orthogonal Thinker COO Alex Speiser also hyped up Psilly.

“Anything we do or will do starts from whole plants," Speiser said. "Our proprietary psilocybin molecule was developed to be true to the essence of psilocybin mushrooms and true to the legacy of psychedelic science. We have achieved our goal of coming up with something that is ‘better’ but still has the heart of the whole plant. This has always been and will continue to be the goal with our R&D.”

Photo by Javier Hasse.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.


Related Articles

How Dr. Monnica Williams Created Canada's First Psychedelic Master's Degree Program: 'Nobody Took Me Seriously'

How Dr. Monnica Williams Created Canada's First Psychedelic Master's Degree Program: 'Nobody Took Me Seriously'

This article by Carrie Dagenhard was originally published on Psychedelic Spotlight and appears here with permission. read more
DEA Raises Production Quota For Psychedelics Like MDMA, Psilocybin and DMT As Research Flourishes

DEA Raises Production Quota For Psychedelics Like MDMA, Psilocybin and DMT As Research Flourishes

The Drug Enforcement Administration (DEA), has increased its quota for the legal production of psychedelic drugs such as psilocybin (also known as magic mushrooms), MDMA and DMT for 2022.  read more
Seelos Raises $20M, Acquires Ketamine Tech, And Announces New Drug

Seelos Raises $20M, Acquires Ketamine Tech, And Announces New Drug

This article was originally published on Microdose Psychedelic Insights and appears here with permission. read more
Ayahuasca Helped Will Smith 'Surrender' And More Psychedelic Revelations From Actor's Memoir 'Will'

Ayahuasca Helped Will Smith 'Surrender' And More Psychedelic Revelations From Actor's Memoir 'Will'

This article by Greg Gilman was originally published on Psychedelic Spotlight, and appears here with permission. read more